Top Markets
#1 BSquared Network BSquared Network +86.70%
#2 Derive Derive +34.14%
#3 Akedo Akedo +30.98%
#4 DogBull DogBull +30.84%
#5 Arweave Arweave +23.96%
#6 MetaDAO MetaDAO +22.00%
#7 Zama Zama +21.78%
#8 Tezos Tezos +17.94%
#9 Cortex Cortex +14.73%
#10 Kinetiq Kinetiq +14.65%
Coin of the day
BSquared Network BSquared Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Classifica tra le azioni #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Prezzo delle azioni
$150.78
Ultima sincronizzazione: 2026-09-18
Capitalizzazione di mercato
$187.20B
Variazione (1 giorno)
-0.08%
Variazione (1 anno)
32.15%
Paese
US
Scambia Gilead Sciences, Inc. (GILD)

Categoria

Healthcare
EPS per Gilead Sciences, Inc. (GILD)
EPS al June 2026 TTM: $-2.60
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Gilead Sciences, Inc., l’EPS attuale della società (TTM) è $-2.60. Alla fine del 2024, la società aveva un EPS di $0.38 una diminuzione rispetto a rispetto a quello del 2023, che era di $4.54.
Storico EPS per Gilead Sciences, Inc. da 2000 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-2.60 -138.01%
2025 $6.84 1,700.00%
2024 $0.38 -91.63%
2023 $4.54 24.04%
2022 $3.66 -26.21%
2021 $4.96 4,966.39%
2020 $0.10 -97.69%
2019 $4.24 0.95%
2018 $4.20 18.64%
2017 $3.54 -64.88%
2016 $10.08 -18.51%
2015 $12.37 55.60%
2014 $7.95 295.52%
2013 $2.01 17.54%
2012 $1.71 -5.52%
2011 $1.81 6.47%
2010 $1.70 16.44%
2009 $1.46 33.94%
2008 $1.09 25.29%
2007 $0.87 -233.85%
2006 $-0.65 -244.44%
2005 $0.45 73.08%
2004 $0.26 -680.36%
2003 $-0.04 -196.76%
2002 $0.05 32.29%
2001 $0.04 -189.74%
2000 $-0.04 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -1,248.08%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -432.69%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -236.54%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -884.19%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -148.46%
US